LEADER 01574nam  2200433   450 
001 9910717043303321
005 20211227112925.0
035   $a(CKB)5470000002527774
035   $a(OCoLC)1290170456
035   $a(EXLCZ)995470000002527774
100   $a20211227d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCBO's simulation model of new drug development /$fChristopher P. Adams
210  1$aWashington, D.C. :$cCongressional Budget Office,$d2021.
215   $a1 online resource (28 pages, 1 unnumbered page) $ccolor illustrations
225 1 $aWorking paper ;$v2021-09
300   $a"August 2021."
320   $aIncludes bibliographical references (pages 26-28).
517 3 $aCongressional Budget Office's simulation model of new drug development
606   $aDrug development$zUnited States$xSimulation methods
606   $aPrescription pricing$xGovernment policy$zUnited States
606   $aPharmaceutical policy$zUnited States
606   $aDrugs$xPrices$zUnited States
615  0$aDrug development$xSimulation methods.
615  0$aPrescription pricing$xGovernment policy
615  0$aPharmaceutical policy
615  0$aDrugs$xPrices
700   $aAdams$b Christopher P.$01387614
712 02$aUnited States.$bCongressional Budget Office,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910717043303321
996   $aCBO's simulation model of new drug development$93438940
997   $aUNINA